Provenance Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Provenance Wealth Advisors's PCRX Position: Q3 2026 in Review
Provenance Wealth Advisors held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 150 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.
Provenance Wealth Advisors first reported a position in PCRX in Q3 2023 and has held it in 13 quarters since. The position peaked at $5.06K in Q4 2023. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Provenance Wealth Advisors held 150 shares of Pacira BioSciences worth $3.76K as of Q3 2026.
- Provenance Wealth Advisors left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up ﹤0.01% of Provenance Wealth Advisors's portfolio in Q3 2026, its #1557 holding.
- Provenance Wealth Advisors first reported a position in Pacira BioSciences in Q3 2023 and has held it in 13 quarters since.
- Provenance Wealth Advisors's Pacira BioSciences position peaked at $5.06K in Q4 2023.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Provenance Wealth Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.